CLASS II Drug recall · Reported 8 Sep 2021 · FDA Enforcement Report
Clopidogrel Tablets, USP, 75 mg recalled by Macleods Pharma Usa
Macleods Pharma Usa is recalling Clopidogrel Tablets, USP, 75 mg, distributed nationwide in the US. The recall was initiated on 2 Aug 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0787-2021
- FDA event ID
- 88391
- Recalling firm
- Macleods Pharma Usa, Plainsboro, NJ
- Brand
- Clopidogrel
- Manufacturer
- Macleods Pharmaceuticals Limited
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 2 Aug 2021
- FDA classified
- 31 Aug 2021
- Reported
- 8 Sep 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Foreign Material
- Drug class
- Blood Thinners
Timeline
| 2 Aug 2021 | Recall initiated by company | |
| 31 Aug 2021 | Classified by FDA | +29 days |
| 8 Sep 2021 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of foreign matter
Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.
Product as listed by the FDA
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15
Where it was distributed
Product was distributed nationwide.
Questions about this recall
Why was it recalled?
Presence of foreign matter
Which lots are affected?
Lot # BCA82021A, Exp 06/2023
Where was it sold?
Product was distributed nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Macleods Pharma Usa
All 35| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Olmesartan Medoxomil, Amlodipine recalled by Macleods Pharma USAOlmesartan Medoxomil Amlodipine And Hydrochlorothiazide | Macleods Pharma USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothyroxine Sodium Tablets USP 150 mcg recalled by Macleods Pharma UsaLevothyroxine Sodium | Macleods Pharma USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Losartan Potassium and Hydrochlorothiazide Tablets recalledLosartan Potassium And Hydrochlorothiazide | Macleods Pharma USA | Foreign Material | Nationwide |
| Drug | CLASS III | Levofloxacin Tablets, USP 500 mg recalled by Macleods Pharma Usa | Macleods Pharma USA | Packaging Defects | Nationwide |
| Drug | CLASS II | Eszopiclone Tablets, USP 1 mg recalled by Macleods Pharma UsaEszopiclone | Macleods Pharma Usa | Packaging Defects | Nationwide |
Other Clopidogrel recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clopidogrel Tablets USP, 75 mg recalled by Preferred Pharmaceuticals | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Clopidogrel Tablets USP, 75 mg recalled by Accord Healthcare | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS I | Clopidogrel Tablets, USP 75 mg recalled by International Laboratories | International Laboratories | Packaging Defects | Nationwide |